FDA Updates Hydrochlorothiazide Label for Nonmelanoma Skin Cancer
Hydrochlorothiazide is associated with an increased risk of nonmelanoma skin cancer, according to updates to the medication’s label.
Hydrochlorothiazide is associated with an increased risk of nonmelanoma skin cancer, according to updates to the medication’s label.
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest…
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
Register Now Thursday, May 23, 2024 Time: 11:30 – 12:15 pm ET / 5:30 – 6:15 pm CET CME | CNE | CPE Virtual The…
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
Friday, May 3, 2024 | 1:30 pm – 2:30 pm CT Supported by an independent educational grant from Servier. Three pioneers in awake brain surgery,…
Sunday, June 2, 2024 | 6:45 pm – 8:15 pm CT Supported by an independent educational grant from Takeda Pharmaceuticals, Inc. Join us in Chicago…
Saturday, May 4, 2024 | 6:30 am – 8:00 am ET Supported by an independent educational grant from ACADIA Pharmaceuticals Inc. Rett syndrome (RTT) is…
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…